75 related articles for article (PubMed ID: 23060562)
1. Loss of expression of growth differentiation factor-9 (GDF9) in human kidney cancer and regulation of growth and migration of kidney cancer cells by GDF9.
Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2012 Oct; 32(10):4375-83. PubMed ID: 23060562
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.
Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
Int J Mol Med; 2012 Mar; 29(3):428-34. PubMed ID: 22159313
[TBL] [Abstract][Full Text] [Related]
3. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
4. The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway.
Du P; Ye L; Li H; Yang Y; Jiang WG
J Exp Ther Oncol; 2012; 10(2):91-9. PubMed ID: 23350348
[TBL] [Abstract][Full Text] [Related]
5. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
[TBL] [Abstract][Full Text] [Related]
7. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
Du P; Ye L; Ruge F; Yang Y; Jiang WG
Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.
Kim IY; Lee DH; Lee DK; Kim BC; Kim HT; Leach FS; Linehan WM; Morton RA; Kim SJ
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6046-51. PubMed ID: 14676131
[TBL] [Abstract][Full Text] [Related]
10. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor 9 and its spatiotemporal expression and regulation in the zebrafish ovary.
Liu L; Ge W
Biol Reprod; 2007 Feb; 76(2):294-302. PubMed ID: 17093199
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein-4 is overexpressed in colonic adenocarcinomas and promotes migration and invasion of HCT116 cells.
Deng H; Makizumi R; Ravikumar TS; Dong H; Yang W; Yang WL
Exp Cell Res; 2007 Mar; 313(5):1033-44. PubMed ID: 17275810
[TBL] [Abstract][Full Text] [Related]
14. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
Li Y; Chen N; Yu HJ; Dong XP; Huang QH
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):544-8. PubMed ID: 16681885
[TBL] [Abstract][Full Text] [Related]
15. EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.
Liu Y; Sanders AJ; Zhang L; Jiang WG
Anticancer Res; 2012 Apr; 32(4):1283-9. PubMed ID: 22493360
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
17. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.
Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A
Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895
[TBL] [Abstract][Full Text] [Related]
18. Expression of growth differentiation factor 9 (GDF9) and its receptor in adult cat testis.
Zhao L; He J; Guo Q; Wen X; Zhang X; Dong C
Acta Histochem; 2011 Dec; 113(8):771-6. PubMed ID: 21146857
[TBL] [Abstract][Full Text] [Related]
19. Extra-ovarian expression and activity of growth differentiation factor 9.
Wang Y; Nicholls PK; Stanton PG; Harrison CA; Sarraj M; Gilchrist RB; Findlay JK; Farnworth PG
J Endocrinol; 2009 Sep; 202(3):419-30. PubMed ID: 19505950
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor 9 (Gdf9) was localized in the female as well as male germ cells in a protogynous hermaphroditic teleost fish, ricefield eel Monopterus albus.
He Z; Wu Y; Xie J; Wang T; Zhang L; Zhang W
Gen Comp Endocrinol; 2012 Sep; 178(2):355-62. PubMed ID: 22732078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
